vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and NICOLET BANKSHARES INC (NIC). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $104.0M, roughly 1.2× NICOLET BANKSHARES INC). NICOLET BANKSHARES INC runs the higher net margin — 38.8% vs 3.3%, a 35.5% gap on every dollar of revenue. On growth, NICOLET BANKSHARES INC posted the faster year-over-year revenue change (12.5% vs 4.7%). NICOLET BANKSHARES INC produced more free cash flow last quarter ($149.4M vs $7.6M). Over the past eight quarters, NICOLET BANKSHARES INC's revenue compounded faster (12.5% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.
NATR vs NIC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $104.0M |
| Net Profit | $4.1M | $40.3M |
| Gross Margin | 72.5% | — |
| Operating Margin | 4.3% | 48.3% |
| Net Margin | 3.3% | 38.8% |
| Revenue YoY | 4.7% | 12.5% |
| Net Profit YoY | 1379.4% | 16.9% |
| EPS (diluted) | $0.23 | $2.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $104.0M | ||
| Q3 25 | $128.3M | $102.9M | ||
| Q2 25 | $114.8M | $95.7M | ||
| Q1 25 | $113.2M | $89.4M | ||
| Q4 24 | $118.2M | $92.4M | ||
| Q3 24 | $114.6M | $90.7M | ||
| Q2 24 | $110.6M | $85.0M | ||
| Q1 24 | $111.0M | $82.2M |
| Q4 25 | $4.1M | $40.3M | ||
| Q3 25 | $5.3M | $41.7M | ||
| Q2 25 | $5.3M | $36.0M | ||
| Q1 25 | $4.7M | $32.6M | ||
| Q4 24 | $-321.0K | $34.5M | ||
| Q3 24 | $4.3M | $32.5M | ||
| Q2 24 | $1.3M | $29.3M | ||
| Q1 24 | $2.3M | $27.8M |
| Q4 25 | 72.5% | — | ||
| Q3 25 | 73.3% | — | ||
| Q2 25 | 71.7% | — | ||
| Q1 25 | 72.1% | — | ||
| Q4 24 | 72.0% | — | ||
| Q3 24 | 71.3% | — | ||
| Q2 24 | 71.4% | — | ||
| Q1 24 | 71.2% | — |
| Q4 25 | 4.3% | 48.3% | ||
| Q3 25 | 7.0% | 50.4% | ||
| Q2 25 | 3.7% | 46.8% | ||
| Q1 25 | 5.4% | 44.9% | ||
| Q4 24 | 3.8% | 46.8% | ||
| Q3 24 | 4.6% | 45.0% | ||
| Q2 24 | 5.1% | 43.3% | ||
| Q1 24 | 4.2% | 41.8% |
| Q4 25 | 3.3% | 38.8% | ||
| Q3 25 | 4.2% | 40.6% | ||
| Q2 25 | 4.6% | 37.6% | ||
| Q1 25 | 4.2% | 36.4% | ||
| Q4 24 | -0.3% | 37.3% | ||
| Q3 24 | 3.8% | 35.8% | ||
| Q2 24 | 1.2% | 34.5% | ||
| Q1 24 | 2.1% | 33.8% |
| Q4 25 | $0.23 | $2.63 | ||
| Q3 25 | $0.30 | $2.73 | ||
| Q2 25 | $0.28 | $2.34 | ||
| Q1 25 | $0.25 | $2.08 | ||
| Q4 24 | $-0.02 | $2.21 | ||
| Q3 24 | $0.23 | $2.10 | ||
| Q2 24 | $0.07 | $1.92 | ||
| Q1 24 | $0.12 | $1.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | — |
| Total DebtLower is stronger | — | $134.9M |
| Stockholders' EquityBook value | $161.6M | $1.3B |
| Total Assets | $261.1M | $9.2B |
| Debt / EquityLower = less leverage | — | 0.11× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | — | ||
| Q3 25 | $95.6M | — | ||
| Q2 25 | $81.3M | — | ||
| Q1 25 | $86.5M | — | ||
| Q4 24 | $84.7M | — | ||
| Q3 24 | $78.7M | — | ||
| Q2 24 | $68.7M | — | ||
| Q1 24 | $77.8M | — |
| Q4 25 | — | $134.9M | ||
| Q3 25 | — | $134.6M | ||
| Q2 25 | — | $134.3M | ||
| Q1 25 | — | $156.6M | ||
| Q4 24 | — | $161.4M | ||
| Q3 24 | — | $161.2M | ||
| Q2 24 | — | $162.4M | ||
| Q1 24 | $2.1M | $162.3M |
| Q4 25 | $161.6M | $1.3B | ||
| Q3 25 | $166.7M | $1.2B | ||
| Q2 25 | $163.7M | $1.2B | ||
| Q1 25 | $167.1M | $1.2B | ||
| Q4 24 | $161.0M | $1.2B | ||
| Q3 24 | $162.6M | $1.1B | ||
| Q2 24 | $156.4M | $1.1B | ||
| Q1 24 | $159.7M | $1.1B |
| Q4 25 | $261.1M | $9.2B | ||
| Q3 25 | $264.8M | $9.0B | ||
| Q2 25 | $254.9M | $8.9B | ||
| Q1 25 | $252.7M | $9.0B | ||
| Q4 24 | $240.9M | $8.8B | ||
| Q3 24 | $245.3M | $8.6B | ||
| Q2 24 | $235.8M | $8.6B | ||
| Q1 24 | $247.3M | $8.4B |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.11× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | 0.01× | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $153.5M |
| Free Cash FlowOCF − Capex | $7.6M | $149.4M |
| FCF MarginFCF / Revenue | 6.1% | 143.7% |
| Capex IntensityCapex / Revenue | 1.9% | 3.9% |
| Cash ConversionOCF / Net Profit | 2.41× | 3.81× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $275.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $153.5M | ||
| Q3 25 | $18.5M | $45.9M | ||
| Q2 25 | $4.3M | $38.9M | ||
| Q1 25 | $2.6M | $41.8M | ||
| Q4 24 | $12.2M | $133.7M | ||
| Q3 24 | $9.6M | $39.6M | ||
| Q2 24 | $1.3M | $37.3M | ||
| Q1 24 | $2.2M | $23.4M |
| Q4 25 | $7.6M | $149.4M | ||
| Q3 25 | $16.8M | $45.9M | ||
| Q2 25 | $3.0M | $38.4M | ||
| Q1 25 | $1.5M | $41.3M | ||
| Q4 24 | $10.0M | $116.8M | ||
| Q3 24 | $7.9M | $34.7M | ||
| Q2 24 | $-2.0M | $34.4M | ||
| Q1 24 | $-1.5M | $20.1M |
| Q4 25 | 6.1% | 143.7% | ||
| Q3 25 | 13.1% | 44.6% | ||
| Q2 25 | 2.6% | 40.1% | ||
| Q1 25 | 1.3% | 46.2% | ||
| Q4 24 | 8.5% | 126.4% | ||
| Q3 24 | 6.9% | 38.3% | ||
| Q2 24 | -1.9% | 40.5% | ||
| Q1 24 | -1.4% | 24.4% |
| Q4 25 | 1.9% | 3.9% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 1.2% | 0.6% | ||
| Q1 25 | 1.0% | 0.5% | ||
| Q4 24 | 1.9% | 18.3% | ||
| Q3 24 | 1.5% | 5.4% | ||
| Q2 24 | 3.0% | 3.5% | ||
| Q1 24 | 3.3% | 4.0% |
| Q4 25 | 2.41× | 3.81× | ||
| Q3 25 | 3.46× | 1.10× | ||
| Q2 25 | 0.81× | 1.08× | ||
| Q1 25 | 0.55× | 1.28× | ||
| Q4 24 | — | 3.88× | ||
| Q3 24 | 2.21× | 1.22× | ||
| Q2 24 | 0.97× | 1.28× | ||
| Q1 24 | 0.94× | 0.84× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
NIC
Segment breakdown not available.
